<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="jah39720" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Heart Assoc</journal-id><journal-id journal-id-type="iso-abbrev">J Am Heart Assoc</journal-id><journal-id journal-id-type="pmc-domain-id">1888</journal-id><journal-id journal-id-type="pmc-domain">jaha</journal-id><journal-id journal-id-type="publisher-id">JAH3</journal-id><journal-title-group><journal-title>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</journal-title></journal-title-group><issn pub-type="epub">2047-9980</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11292772</article-id><article-id pub-id-type="pmcid-ver">PMC11292772.1</article-id><article-id pub-id-type="pmcaid">11292772</article-id><article-id pub-id-type="pmcaiid">11292772</article-id><article-id pub-id-type="pmid">38958132</article-id><article-id pub-id-type="doi">10.1161/JAHA.123.033463</article-id><article-id pub-id-type="publisher-id">JAH39720</article-id><article-id pub-id-type="other">JAHA/2023/033463-T</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Research</subject><subj-group subj-group-type="heading"><subject>Epidemiology</subject></subj-group></subj-group></article-categories><title-group><article-title>Trends and Factors Associated With Peripheral Vascular Interventions for the Treatment of Claudication From 2011 to 2022: A National Medicare Cohort Study</article-title><alt-title alt-title-type="right-running-head"><styled-content style="fixed-case" toggle="no">PVI</styled-content> Trends for Treatment of Claudication</alt-title><alt-title alt-title-type="left-running-head">Dun et&#160;al</alt-title></title-group><contrib-group><contrib id="jah39720-cr-0001" contrib-type="author"><name name-style="western"><surname>Dun</surname><given-names initials="C">Chen</given-names></name><degrees>MHS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4220-5939</contrib-id><xref rid="jah39720-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="jah39720-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="jah39720-cr-0002" contrib-type="author"><name name-style="western"><surname>Stonko</surname><given-names initials="DP">David P.</given-names></name><degrees>MD, MS</degrees><xref rid="jah39720-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="jah39720-cr-0003" contrib-type="author"><name name-style="western"><surname>Bose</surname><given-names initials="S">Sanuja</given-names></name><degrees>MD, MPH</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7007-1459</contrib-id><xref rid="jah39720-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="jah39720-cr-0004" contrib-type="author"><name name-style="western"><surname>Keegan</surname><given-names initials="AC">Alana C.</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8145-3209</contrib-id><xref rid="jah39720-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="jah39720-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="jah39720-cr-0005" contrib-type="author"><name name-style="western"><surname>McDermott</surname><given-names initials="KM">Katherine M.</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2166-524X</contrib-id><xref rid="jah39720-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="jah39720-cr-0006" contrib-type="author"><name name-style="western"><surname>Rumalla</surname><given-names initials="KC">Kranti C.</given-names></name><degrees>BA</degrees><xref rid="jah39720-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="jah39720-cr-0007" contrib-type="author"><name name-style="western"><surname>Black</surname><given-names initials="JH">James H.</given-names><suffix>III</suffix></name><degrees>MD</degrees><xref rid="jah39720-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="jah39720-cr-0008" contrib-type="author"><name name-style="western"><surname>Kalbaugh</surname><given-names initials="CA">Corey A.</given-names></name><degrees>PhD, MS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7455-0369</contrib-id><xref rid="jah39720-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="jah39720-cr-0009" contrib-type="author"><name name-style="western"><surname>Makary</surname><given-names initials="MA">Martin A.</given-names></name><degrees>MD, MPH</degrees><xref rid="jah39720-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="jah39720-aff-0006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib id="jah39720-cr-0010" contrib-type="author" corresp="yes"><name name-style="western"><surname>Hicks</surname><given-names initials="CW">Caitlin W.</given-names></name><degrees>MD, MS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7638-1936</contrib-id><xref rid="jah39720-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><address><email>chicks11@jhmi.edu</email></address></contrib></contrib-group><aff id="jah39720-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Biomedical Informatics and Data Science</named-content>
<institution>Johns Hopkins University School of Medicine</institution>
<city>Baltimore</city>
<named-content content-type="country-part">MD</named-content>
</aff><aff id="jah39720-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Surgery</named-content>
<institution>Johns Hopkins University School of Medicine</institution>
<city>Baltimore</city>
<named-content content-type="country-part">MD</named-content>
</aff><aff id="jah39720-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Division of Vascular Surgery and Endovascular Therapy, Department of Surgery</named-content>
<institution>Johns Hopkins University School of Medicine</institution>
<city>Baltimore</city>
<named-content content-type="country-part">MD</named-content>
</aff><aff id="jah39720-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Surgery</named-content>
<institution>Sinai Hospital of Baltimore</institution>
<city>Baltimore</city>
<named-content content-type="country-part">MD</named-content>
<country country="US">USA</country>
</aff><aff id="jah39720-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Epidemiology and Biostatistics</named-content>
<institution>Indiana University School of Public Health&#8208; Bloomington</institution>
<city>Bloomington</city>
<named-content content-type="country-part">IN</named-content>
<country country="US">USA</country>
</aff><aff id="jah39720-aff-0006">
<label>
<sup>6</sup>
</label>
<institution>Johns Hopkins Carey Business School</institution>
<city>Baltimore</city>
<named-content content-type="country-part">MD</named-content>
<country country="US">USA</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>
Correspondence to: Caitlin W. Hicks, MD, MS, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Halsted 668, Baltimore, MD 21287. Email: <email>chicks11@jhmi.edu</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>03</day><month>7</month><year>2024</year></pub-date><pub-date pub-type="collection"><day>16</day><month>7</month><year>2024</year></pub-date><volume>13</volume><issue seq="100">14</issue><issue-id pub-id-type="pmc-issue-id">467942</issue-id><issue-id pub-id-type="doi">10.1002/jah3.v13.14</issue-id><elocation-id>e033463</elocation-id><history><date date-type="received"><day>06</day><month>2</month><year>2024</year></date><date date-type="accepted"><day>03</day><month>5</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>16</day><month>07</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>02</day><month>08</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-08-28 13:25:29.907"><day>28</day><month>08</month><year>2024</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2024 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#8208;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="JAH3-13-e033463.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:JAH3-13-e033463.pdf"/><abstract><sec id="jah39720-sec-0001"><title>Background</title><p>Previous cross&#8208;sectional studies have identified wide practice pattern variations in the use of peripheral vascular interventions (PVIs) for the treatment of claudication. However, there are limited data on longitudinal practice patterns. We aimed to describe the temporal trends and charges associated with PVI use for claudication over the past 12&#8201;years in the United States.</p></sec><sec id="jah39720-sec-0002"><title>Methods and Results</title><p>We conducted a retrospective analysis using 100% Medicare fee&#8208;for&#8208;service claims data to identify all patients who underwent a PVI for claudication between January 2011 and December 2022. We evaluated the trends in utilization&#160;and Medicare&#8208;allowed charges of PVI according to anatomic level, procedure type, and intervention settings using generalized linear models. Multinomial logistic regressions were used to evaluate factors associated with different levels and types of PVI. We identified 599&#8201;197 PVIs performed for claudication. The proportional use of tibial PVI increased 1.0% per year, and atherectomy increased by 1.6% per year over the study period. The proportion of PVIs performed in ambulatory surgical centers/office&#8208;based laboratories grew at 4% per year from 12.4% in 2011 to 55.7% in 2022. Total Medicare&#8208;allowed charges increased by $11&#8201;980&#8201;035 USD/year. Multinomial logistic regression identified significant associations between race and ethnicity and treatment setting with use of both atherectomy and tibial PVI.</p></sec><sec id="jah39720-sec-0003"><title>Conclusions</title><p>The use of tibial PVI and atherectomy for the treatment of claudication has increased dramatically in in ambulatory surgical center/office&#8208;based laboratory settings, non&#8208;White patients, and resulting in a significant increase in health care charges. There is a critical need to improve the delivery of value&#8208;based care for the treatment of claudication.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jah39720-kwd-0001">claudication</kwd><kwd id="jah39720-kwd-0002">Medicare</kwd><kwd id="jah39720-kwd-0003">peripheral vascular interventions</kwd></kwd-group><kwd-group kwd-group-type="subject-categories"><title>Subject Categories</title><kwd>Vascular Disease</kwd><kwd>Quality and Outcomes</kwd></kwd-group><counts><fig-count count="5"/><table-count count="3"/><page-count count="13"/><word-count count="6800"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>16 July 2024</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.4.5 mode:remove_FC converted:16.07.2024</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="jah39720-ntgp-0001"><fn id="jah39720-note-0001"><p>This article was sent to Amgad Mentias, MD, Associate Editor, for review by expert referees, editorial decision, and final disposition.</p></fn><fn id="jah39720-note-0002"><p>Supplemental Material is available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ahajournals.org/doi/suppl/10.1161/JAHA.123.033463" ext-link-type="uri">https://www.ahajournals.org/doi/suppl/10.1161/JAHA.123.033463</ext-link>
</p></fn><fn id="jah39720-note-0003"><p>For Sources of Funding and Disclosures, see page 12.</p></fn></fn-group></notes></front><body id="jah39720-body-0001"><def-list list-content="abbreviations" id="jah39720-dl-0001"><title>Nonstandard Abbreviations and Acronyms</title><def-item><term id="jah39720-li-0001">ASC/OBL</term><def id="jah39720-li-0002"><p>ambulatory surgical center/office&#8208;based laboratory</p></def></def-item><def-item><term id="jah39720-li-0003">CMS</term><def id="jah39720-li-0004"><p>Centers for Medicare and Medicaid Services</p></def></def-item><def-item><term id="jah39720-li-0005">PVI</term><def id="jah39720-li-0006"><p>peripheral vascular intervention</p></def></def-item><def-item><term id="jah39720-li-0007">VQI</term><def id="jah39720-li-0008"><p>vascular quality initiative</p></def></def-item></def-list><p>
<boxed-text position="anchor" content-type="box" id="jah39720-blkfxd-0001" orientation="portrait"><caption><title>Clinical Perspective</title></caption><sec id="jah39720-sec-0006"><title>What Is New?</title><p>
<list list-type="bullet" id="jah39720-list-0001"><list-item id="jah39720-li-0009"><p>This study is the most up&#8208;to&#8208;date analysis describing the use of peripheral vascular intervention for claudication using longitudinal, nationally representative data.</p></list-item><list-item id="jah39720-li-0010"><p>The use of tibial peripheral vascular intervention and atherectomy for the treatment of claudication has increased dramatically in the past decade, despite poor evidence supporting their efficacy, especially long term.</p></list-item></list>
</p></sec><sec id="jah39720-sec-0007"><title>What Are the Clinical Implications?</title><p>
<list list-type="bullet" id="jah39720-list-0002"><list-item id="jah39720-li-0011"><p>There is a critical need to improve the delivery of equitable, evidence&#8208;based, and value&#8208;based care for the treatment of claudication.</p></list-item></list>
</p></sec></boxed-text>
</p><p>An estimated 6.5&#8201;million people aged 40 and older were living with diagnosed peripheral artery disease (PAD) in the United States in 2021.<xref rid="jah39720-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> Among this population, approximately 10% to 35% have claudication, a disabling condition that causes pain with exercise.<xref rid="jah39720-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Although the gold standard treatment for claudication is best medical therapy, including prescription of antiplatelet agents, statins, smoking cessation, and supervised exercise therapy, a proportion of patients will receive invasive interventions.<xref rid="jah39720-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> The most common invasive revascularization for claudication is now endovascular peripheral vascular interventions (PVIs), which have overtaken open surgical revascularization procedures in the past 2 decades. Endovascular PVI is now the most common first&#8208;line invasive procedure in adults with claudication.<xref rid="jah39720-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>
</p><p>Recently, concerns have been raised about the potential overuse of PVI for the treatment of claudication.<xref rid="jah39720-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="jah39720-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="jah39720-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="jah39720-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="jah39720-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> In patients who are not first optimally managed via conservative approaches, PVI may be considered low&#8208;value care or clinically unnecessary. We have previously demonstrated higher rates of repeat PVIs, accelerated PAD progression, and higher risk of major amputation in patients managed with early PVI compared with early conservative therapy for claudication, with highest risk among adults treated with atherectomy compared with other endovascular technologies.<xref rid="jah39720-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="jah39720-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> Therefore, among patients who are not optimally managed via conservative approaches, PVI may be low value, medically unnecessary, or even harmful. Low&#8208;value PVI not only exposes patients to unnecessary risks but also diverts critical resources away from more effective treatments for PAD.</p><p>Previous cross&#8208;sectional studies using data from the VQI (Vascular Quality Initiative) registry have shown wide practice pattern variations in the use of PVI for the treatment of claudication. However, the VQI is limited to voluntarily participating institutions and, thus, we lack nationally representative data on longitudinal practice patterns and related health care expenditures.<xref rid="jah39720-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> The objective of this study was to describe the temporal trends and Medicare&#8208;allowed charges associated with PVI use for claudication over the past 12&#8201;years in the United States and evaluate the factors associated with PVI for treating claudication.</p><sec sec-type="methods" id="jah39720-sec-0008"><title>METHODS</title><p>All data and materials have been made publicly available and can be accessed at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://resdac.org" ext-link-type="uri">https://resdac.org</ext-link>.</p><sec id="jah39720-sec-0009"><title>Data Source and Study Population</title><p>This was a retrospective analysis using 100% Medicare fee&#8208;for&#8208;service claims data accessed via the US Centers for Medicare and Medicaid Services (CMS) Virtual Research Data Center. We identified all patients who underwent a PVI for claudication between January 1, 2011 and December 31, 2022 using Current Procedural Terminology codes (Table&#160;<xref rid="jah39720-supitem-0001" ref-type="supplementary-material">S1</xref>). PVI involving drug&#8208;coated balloons and intravascular lithotripsy could not be distinguished from traditional balloon angioplasty in this analysis. Patients with claudication were identified using <italic toggle="yes">International Classification of Diseases, Ninth Revision</italic> (<italic toggle="yes">ICD&#8208;9</italic>) and <italic toggle="yes">Tenth Revision</italic> (<italic toggle="yes">ICD&#8208;10</italic>) codes based on previous studies<xref rid="jah39720-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="jah39720-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="jah39720-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> (Table&#160;<xref rid="jah39720-supitem-0001" ref-type="supplementary-material">S2</xref>). We excluded patients without 12&#8201;months of continuous enrollment in Medicare before their index PVI (n=101&#8201;738), of age &lt;18&#8201;years (n=13), and those missing demographic information (n=321). Patients with any diagnosis of acute limb ischemia (n=651&#8201;215), or chronic limb&#8208;threatening ischemia (n=1&#8201;764&#8201;509) within 12&#8201;months before their index PVI procedure were also excluded (Table&#160;<xref rid="jah39720-supitem-0001" ref-type="supplementary-material">S2</xref>). Approval was obtained from the Johns Hopkins Medicine Institutional Review Board. Medicare data were analyzed in a retrospective manner and consent was not required.</p></sec><sec id="jah39720-sec-0010"><title>Patient Characteristics</title><p>We obtained patient demographic information including age, sex, race, and ZIP code of residence from the Medicare Master Beneficiary Summary File.<xref rid="jah39720-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> ZIP codes were mapped to a Federal Information Processing Standard code using the sashelp.zipcode file (SAS Institute, Cary, NC). The Federal Information Processing Standard code was then mapped to a core&#8208;based statistical area code using a core&#8208;based statistical area to Federal Information Processing Standard County Crosswalk from the National Bureau of Economic Research.<xref rid="jah39720-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> Core&#8208;based statistical area codes were used to determine whether the patient's place of residence was metropolitan (urban core of &#8805;50&#8201;000 population) or micropolitan (a nonmetropolitan/rural area with &lt;50&#8201;000 population).<xref rid="jah39720-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> The census region of residence were drawn based on home ZIP code according to national geographic regions.<xref rid="jah39720-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> For each patient who underwent a PVI for claudication, we reviewed all inpatient, outpatient, and carrier claims in the 12&#8201;months preceding the date of the procedure in order to identify comorbidities, including end&#8208;stage kidney disease, diabetes, hypertension, and smoking history. Comorbidities status was based on a single inpatient diagnosis claim or at least 2 outpatient diagnosis claims &gt;30&#8201;days apart. We obtained place of service codes to categorize the site of service where a PVI was performed.</p></sec><sec id="jah39720-sec-0011"><title>Outcomes</title><p>The main outcome for the study was the use of PVI for claudication over time, evaluated by anatomic level, PVI type, and site of service. We categorized anatomic level as iliac, femoropopliteal, and tibial. We categorized procedure type as isolated angioplasty, isolated stent, isolated atherectomy, or stent with atherectomy, based on the Current Procedural Terminology codes (Table&#160;<xref rid="jah39720-supitem-0001" ref-type="supplementary-material">S1</xref>). PVI of the same type occurring at the same anatomic level on the same day were considered to be 1 procedure. PVIs at multiple levels on the same day were considered separate procedures. Site of service was categorized as ambulatory surgical center or office&#8208;based laboratory (ASC/OBL) or hospital (inpatient or outpatient or other).<xref rid="jah39720-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>
</p><p>We also examined the relationship between the trends in PVI use and Medicare&#8208;allowed charges and evaluated patient characteristics associated with use of different levels and types of PVI. Medicare&#8208;allowed charges is the total payment allowed for the service from a professional claim and includes both the Medicare and patient&#8208;paid amount.<xref rid="jah39720-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>
</p></sec><sec id="jah39720-sec-0012"><title>Statistical Analysis</title><p>Sample demographic, clinical, and procedural characteristics were reported as mean&#177;SE (estimated using the sandwich [robust] estimator) or median (interquartile range) for normally and nonnormally distributed continuous variables, respectively, and as proportions for categorical variables. We plotted the number and the proportion of PVI by level, type, and site of service overall and by year. Chi&#8208;square tests were used to compare differences between categorical variables, and Cochran&#8211;Mantel&#8211;Haenszel trends tests were used to compare within&#8208;category differences over time. Univariate multinomial logistic regression analyses were used to identify individual factors associated with the level of PVI and type of PVI, separately. We calculated the variance inflation factor and checked tolerance values to ensure there was no collinearity between covariates. We tested the linearity assumption for year by performing a linear regression analysis and plotting the results visually. A multilevel multivariate multinomial logistic regression was then used to identify factors associated with each outcome after controlling for patient demographic characteristics (age, sex, race, ethnicity, population density, region of residence), comorbidities (end&#8208;stage kidney disease, diabetes, hypertension, and smoking history), site of service, and year that the intervention was performed using an a priori approach. Relative risk ratios were used to report associations among patient characteristics, site of service, and geographic factors according to anatomic levels and PVI types. All multivariable models were clustered by patient to account for the fact that each individual patient may have contributed to multiple observations. Generalized linear regression models with a Gaussian distribution were used to assess the associations of level of PVI, type of PVI, and Medicare&#8208;allowed charge amount for calendar year in order to understand the crude (unadjusted) change in Medicare&#8208;allowed charges over time. Statistical significance was set at <italic toggle="yes">P</italic>&lt;0.05 for all analyses. Statistical analyses were performed using Joinpoint (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://surveillance.cancer.gov/joinpoint/" ext-link-type="uri">https://surveillance.cancer.gov/joinpoint/</ext-link>) and SAS Enterprise Version 7.1 (SAS Institute, Cary, NC).</p></sec></sec><sec sec-type="results" id="jah39720-sec-0013"><title>RESULTS</title><sec id="jah39720-sec-0014"><title>Study Population</title><p>A total of 599&#8201;197 PVIs were performed on 316&#8201;183 patients over the course of the 12&#8208;year study period. The median (interquartile range) age at the time of intervention was 73.7&#8201;years (interquartile range 68.6&#8211;79.5&#8201;years). The majority of patients undergoing PVI were male (58.1%), non&#8208;Hispanic White (80.7%), diagnosed with hypertension (66.0%), residing in urban areas (78.6%), and most commonly located in the South (48.6%) (Table&#160;<xref rid="jah39720-tbl-0001" ref-type="table">1</xref>). The overall number of PVIs increased from 2011 to 2014, dipped until 2016, resumed growth until 2019, and then declined again through 2022 (Figure&#160;<xref rid="jah39720-fig-0001" ref-type="fig">1</xref>).</p><table-wrap position="float" id="jah39720-tbl-0001" content-type="Table" orientation="portrait"><label>Table 1</label><caption><p>Characteristics of Medicare Patients Who Underwent Endovascular PVIs for Claudication Between 2011 and 2022</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="left" rowspan="1" colspan="1">Number (%) of PVIs (N=599&#8201;197)</th></tr></thead><tbody><tr><td align="left" colspan="2" rowspan="1">Age, y</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Median (interquartile range)</td><td align="left" rowspan="1" colspan="1">73.7 (68.6&#8211;79.5)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">&#8804;64</td><td align="left" rowspan="1" colspan="1">68&#8201;822 (11.5)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">65&#8211;74</td><td align="left" rowspan="1" colspan="1">266&#8201;441 (44.5)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">75&#8211;84</td><td align="left" rowspan="1" colspan="1">209&#8201;883 (35.0)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">&#8805;85</td><td align="left" rowspan="1" colspan="1">54&#8201;051 (9.0)</td></tr><tr><td align="left" colspan="2" rowspan="1">Sex</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">251&#8201;010 (41.9)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">348&#8201;187 (58.1)</td></tr><tr><td align="left" colspan="2" rowspan="1">Race</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">White</td><td align="left" rowspan="1" colspan="1">483&#8201;608 (80.7)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Black</td><td align="left" rowspan="1" colspan="1">74&#8201;293 (12.4)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">6834 (1.1)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hispanic</td><td align="left" rowspan="1" colspan="1">19&#8201;710 (3.3)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Other<xref rid="jah39720-note-0004" ref-type="table-fn">
<sup>*</sup>
</xref>/unknown</td><td align="left" rowspan="1" colspan="1">14&#8201;752 (2.5)</td></tr><tr><td align="left" colspan="2" rowspan="1">Comorbidities</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">End&#8208;stage kidney disease</td><td align="left" rowspan="1" colspan="1">70&#8201;766 (11.8)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Diabetes</td><td align="left" rowspan="1" colspan="1">203&#8201;036 (33.9)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hypertension</td><td align="left" rowspan="1" colspan="1">395&#8201;576 (66.0)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Ever smoking</td><td align="left" rowspan="1" colspan="1">256&#8201;632 (42.8)</td></tr><tr><td align="left" colspan="2" rowspan="1">Population density of residence</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Urban</td><td align="left" rowspan="1" colspan="1">471&#8201;127 (78.6)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Rural</td><td align="left" rowspan="1" colspan="1">128&#8201;070 (21.4)</td></tr><tr><td align="left" colspan="2" rowspan="1">Census region of residence</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Midwest</td><td align="left" rowspan="1" colspan="1">127&#8201;330 (21.3)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Northeast</td><td align="left" rowspan="1" colspan="1">73&#8201;132 (12.2)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">South</td><td align="left" rowspan="1" colspan="1">291&#8201;409 (48.6)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">West</td><td align="left" rowspan="1" colspan="1">106&#8201;590 (17.8)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Other</td><td align="left" rowspan="1" colspan="1">736 (0.1)</td></tr><tr><td align="left" colspan="2" rowspan="1">Anatomic level of intervention</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Femoropopliteal</td><td align="left" rowspan="1" colspan="1">327&#8201;343 (54.6)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Iliac</td><td align="left" rowspan="1" colspan="1">161&#8201;748 (27.0)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Tibial</td><td align="left" rowspan="1" colspan="1">110&#8201;106 (18.4)</td></tr><tr><td align="left" colspan="2" rowspan="1">Type of intervention</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Angioplasty</td><td align="left" rowspan="1" colspan="1">162&#8201;578 (27.1)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Stent</td><td align="left" rowspan="1" colspan="1">195&#8201;659 (32.7)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Atherectomy</td><td align="left" rowspan="1" colspan="1">178&#8201;006 (29.7)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Stent with atherectomy</td><td align="left" rowspan="1" colspan="1">62&#8201;954 (10.5)</td></tr><tr><td align="left" colspan="2" rowspan="1">Site of service</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hospital/other</td><td align="left" rowspan="1" colspan="1">375&#8201;991 (62.8)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Ambulatory surgical center/office&#8208;based laboratory</td><td align="left" rowspan="1" colspan="1">223&#8201;206 (37.3)</td></tr></tbody></table><table-wrap-foot id="jah39720-ntgp-0002"><fn id="jah39720-note-0004"><p>ASC/OBL indicates ambulatory surgical center or office&#8208;based laboratory; and PVI, peripheral vascular intervention.</p></fn><fn id="jah39720-note-1004"><label>
<sup>*</sup>
</label><p>Other includes American Indian or Alaska Native</p></fn></table-wrap-foot></table-wrap><fig position="float" fig-type="Figure" id="jah39720-fig-0001" orientation="portrait"><label>Figure 1</label><caption><title>Number of PVI performed for claudication per year in the Medicare population, 2011 to 2022.</title><p>APC indicates annual percentage change; and PVI, peripheral vascular interventions.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="JAH3-13-e033463-g001.jpg"/></fig></sec><sec id="jah39720-sec-0015"><title>Anatomic Level of <styled-content style="fixed-case" toggle="no">PVI</styled-content>
</title><p>Overall, the majority (54.6%) of PVIs for claudication were performed at the femoropopliteal level, followed by the iliac (27.0%), and tibial (18.4%) levels. Among the PVIs involving a tibial intervention, 63% were conducted concurrently with another procedure, either at the iliac or femoropopliteal level. Nine percent of PVIs included concomitant iliac and femoropopliteal interventions, and 1% of PVIs included treatment of all 3 anatomic levels during the same procedure. Over the 12&#8208;year study period, the femoropopliteal PVI rate remained consistent (53.2%&#8211;55.7%), whereas the iliac PVI rate decreased from 32.4% in 2011 to 22.3% in 2022, and the tibial PVI rate increased from 13.2% in 2010 to 23.3% in 2022 (Figure&#160;<xref rid="jah39720-fig-0002" ref-type="fig">2A</xref>). The mean increase in tibial PVI for claudication was 1.0% per year (95% CI, 0.8%&#8211;1.2%).</p><fig position="float" fig-type="Figure" id="jah39720-fig-0002" orientation="portrait"><label>Figure 2</label><caption><title>Proportion of PVI performed for claudication per year according to anatomic level (A) and PVI type (B).</title><p>
<bold>A</bold>, Blue=iliac PVI, green=femoropopliteal PVI, gray=tibial PVI. <bold>B</bold>, Blue=angioplasty, Green=atherectomy, gray=stent, pink=stent atherectomy. PVI indicates peripheral vascular interventions.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="JAH3-13-e033463-g002.jpg"/></fig><p>Multilevel multinomial logistic regression was performed to evaluate factors associated with level of PVI (Table&#160;<xref rid="jah39720-tbl-0002" ref-type="table">2</xref>). After adjustment, there were significant differences in the use of iliac and tibial PVI compared with femoropopliteal PVI, according to patient age, sex, race, comorbidities, geographic location factors, and site of service. Iliac PVIs were more common in younger (&lt;65&#8201;years old), female, White patients with end&#8208;stage kidney disease, hypertension, and smoking history, and more frequently performed in hospital settings. In contrast, tibial PVIs were more common in older (&gt;65&#8201;years old), male, non&#8208;White patients with diabetes, and more frequently performed in ASC/OBL settings.</p><table-wrap position="float" id="jah39720-tbl-0002" content-type="Table" orientation="portrait"><label>Table 2</label><caption><p>Multinomial Logistic Regression Models Assessing Patient Characteristics Associated With Anatomic Level of PVIs Performed for Claudication in the Medicare Population, 2011 to 2022</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Covariate</th><th align="left" rowspan="1" colspan="1">Unadjusted relative risk ratio (95% CI)</th><th align="left" rowspan="1" colspan="1">Adjusted relative risk ratio (95% CI)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Femoropopliteal</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" colspan="3" rowspan="1">Iliac</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Age, y</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">&#8804;64</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">65&#8211;74</td><td align="left" rowspan="1" colspan="1">1.068 (1.047&#8211;1.089)</td><td align="left" rowspan="1" colspan="1">1.100 (1.076&#8211;1.124)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">75&#8211;84</td><td align="left" rowspan="1" colspan="1">0.814 (0.803&#8211;0.825)</td><td align="left" rowspan="1" colspan="1">0.833 (0.821&#8211;0.846)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">&#8805;85</td><td align="left" rowspan="1" colspan="1">0.606 (0.591&#8211;0.621)</td><td align="left" rowspan="1" colspan="1">0.631 (0.614&#8211;0.648)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Sex</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">1.044 (1.031&#8211;1.057)</td><td align="left" rowspan="1" colspan="1">1.096 (1.081&#8211;1.111)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Race</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">White</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Non&#8208;White</td><td align="left" rowspan="1" colspan="1">0.546 (0.537&#8211;0.556)</td><td align="left" rowspan="1" colspan="1">0.577 (0.565&#8211;0.588)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Comorbidities</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">ESKD</td><td align="left" rowspan="1" colspan="1">0.983 (0.965&#8211;1.002)</td><td align="left" rowspan="1" colspan="1">1.068 (1.047&#8211;1.090)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Diabetes</td><td align="left" rowspan="1" colspan="1">0.949 (0.937&#8211;0.961)</td><td align="left" rowspan="1" colspan="1">0.764 (0.753&#8211;0.775)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Hypertension</td><td align="left" rowspan="1" colspan="1">1.747 (1.724&#8211;1.770)</td><td align="left" rowspan="1" colspan="1">1.765 (1.739&#8211;1.791)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Ever smoking</td><td align="left" rowspan="1" colspan="1">1.644 (1.624&#8211;1.663)</td><td align="left" rowspan="1" colspan="1">1.378 (1.359&#8211;1.396)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Population density of residence</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Urban</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Rural</td><td align="left" rowspan="1" colspan="1">1.182 (1.166&#8211;1.199)</td><td align="left" rowspan="1" colspan="1">1.072 (1.055&#8211;1.089)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Census region of residence</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Midwest</td><td align="left" rowspan="1" colspan="1">1.147 (1.130&#8211;1.165)</td><td align="left" rowspan="1" colspan="1">0.982 (0.966&#8211;0.999)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Northeast</td><td align="left" rowspan="1" colspan="1">1.163 (1.141&#8211;1.184)</td><td align="left" rowspan="1" colspan="1">1.101 (1.079&#8211;1.125)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">South</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">West</td><td align="left" rowspan="1" colspan="1">1.032 (1.014&#8211;1.049)</td><td align="left" rowspan="1" colspan="1">1.143 (1.121&#8211;1.165)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Other</td><td align="left" rowspan="1" colspan="1">0.767 (0.629&#8211;0.935)</td><td align="left" rowspan="1" colspan="1">0.988 (0.789&#8211;1.237)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Site of service</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Hospital</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">ASC/OBL</td><td align="left" rowspan="1" colspan="1">0.504 (0.497&#8211;0.511)</td><td align="left" rowspan="1" colspan="1">0.595 (0.586&#8211;0.605)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Year, per year</td><td align="left" rowspan="1" colspan="1">0.968 (0.966&#8211;0.970)</td><td align="left" rowspan="1" colspan="1">1.002 (1.000&#8211;1.005)</td></tr><tr><td align="left" colspan="3" rowspan="1">Tibial</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Age, y</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">&#8804;64</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">65&#8211;74</td><td align="left" rowspan="1" colspan="1">1.048 (1.024&#8211;1.074)</td><td align="left" rowspan="1" colspan="1">1.037 (1.009&#8211;1.066)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">75&#8211;84</td><td align="left" rowspan="1" colspan="1">1.281 (1.261&#8211;1.301)</td><td align="left" rowspan="1" colspan="1">1.227 (1.206&#8211;1.248)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">&#8805;85</td><td align="left" rowspan="1" colspan="1">1.660 (1.622&#8211;1.698)</td><td align="left" rowspan="1" colspan="1">1.501 (1.466&#8211;1.538)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Sex</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">0.961 (0.948&#8211;0.975)</td><td align="left" rowspan="1" colspan="1">0.887 (0.873&#8211;0.901)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Race</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">White</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Non&#8208;White</td><td align="left" rowspan="1" colspan="1">1.789 (1.762&#8211;1.817)</td><td align="left" rowspan="1" colspan="1">1.540 (1.514&#8211;1.568)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Comorbidities</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">ESKD</td><td align="left" rowspan="1" colspan="1">1.278 (1.252&#8211;1.304)</td><td align="left" rowspan="1" colspan="1">1.013 (0.993&#8211;1.034)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Diabetes</td><td align="left" rowspan="1" colspan="1">1.169 (1.153&#8211;1.186)</td><td align="left" rowspan="1" colspan="1">1.240 (1.220&#8211;1.260)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Hypertension</td><td align="left" rowspan="1" colspan="1">0.883 (0.871&#8211;0.896)</td><td align="left" rowspan="1" colspan="1">0.972 (0.958&#8211;0.987)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Ever smoking</td><td align="left" rowspan="1" colspan="1">0.530 (0.522&#8211;0.538)</td><td align="left" rowspan="1" colspan="1">0.686 (0.675&#8211;0.698)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Population density of residence</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Urban</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Rural</td><td align="left" rowspan="1" colspan="1">0.833 (0.819&#8211;0.848)</td><td align="left" rowspan="1" colspan="1">1.037 (1.016&#8211;1.058)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Census region of residence</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Midwest</td><td align="left" rowspan="1" colspan="1">0.781 (0.766&#8211;0.796)</td><td align="left" rowspan="1" colspan="1">1.032 (1.009&#8211;1.055)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Northeast</td><td align="left" rowspan="1" colspan="1">0.769 (0.751&#8211;0.787)</td><td align="left" rowspan="1" colspan="1">0.853 (0.831&#8211;0.875)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">South</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">West</td><td align="left" rowspan="1" colspan="1">1.499 (1.473&#8211;1.525)</td><td align="left" rowspan="1" colspan="1">1.312 (1.287&#8211;1.338)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Other</td><td align="left" rowspan="1" colspan="1">1.872 (1.588&#8211;2.206)</td><td align="left" rowspan="1" colspan="1">1.429 (1.217&#8211;1.678)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Site of service</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Hospital</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">ASC/OBL</td><td align="left" rowspan="1" colspan="1">2.856 (2.816&#8211;2.897)</td><td align="left" rowspan="1" colspan="1">2.485 (2.445&#8211;2.525)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Year (annual yearly increase)</td><td align="left" rowspan="1" colspan="1">1.059 (1.057&#8211;1.061)</td><td align="left" rowspan="1" colspan="1">1.005 (1.002&#8211;1.007)</td></tr></tbody></table><table-wrap-foot id="jah39720-ntgp-0003"><fn id="jah39720-note-0005"><p>ASC/OBL indicates ambulatory surgical center or office&#8208;based laboratory; ESKD, end&#8208;stage kidney disease; and PVI, peripheral vascular intervention.</p></fn></table-wrap-foot></table-wrap></sec><sec id="jah39720-sec-0016"><title>Type of <styled-content style="fixed-case" toggle="no">PVI</styled-content>
</title><p>Overall, the most common type of PVI used for treating claudication was an isolated stent (32.7%), followed by isolated atherectomy (29.7%), angioplasty (27.1%), and stent with atherectomy (10.5%). Over the 12&#8208;year study period, the rate of isolated stent use decreased from 44.6% in 2011 to 22.6% in 2022, whereas the atherectomy rate increased from 19.9% to 37.2%, and the use of stent with atherectomy increased from 7.1% to 11.7% (Figure&#160;<xref rid="jah39720-fig-0002" ref-type="fig">2B</xref>). The use of atherectomy significantly increased over time, at a rate of a 1.6% per year (95% CI, 1.4%&#8211;1.8%).</p><p>Multilevel multinomial logistic regression was performed to evaluate factors associated with type of PVI (Table&#160;<xref rid="jah39720-tbl-0003" ref-type="table">3</xref>). Isolated atherectomy and atherectomy with stenting were more commonly used in male, non&#8208;White patients, and more frequently used in ASC/OBL settings. Isolated atherectomy was more commonly used to treat older patients with diabetes, whereas atherectomy with stenting was used to treat younger patients with a smoking history. In contrast, isolated stenting was used more commonly in younger, female, White patients with hypertension and smoking and more frequently used in hospital settings.</p><table-wrap position="float" id="jah39720-tbl-0003" content-type="Table" orientation="portrait"><label>Table 3</label><caption><p>Multinomial Logistic Regression Models Assessing Patient Characteristics Associated With Type of PVI Performed for Claudication in the Medicare Population, 2011 to 2022</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Covariate</th><th align="left" rowspan="1" colspan="1">Unadjusted relative risk ratio (95% CI)</th><th align="left" rowspan="1" colspan="1">Adjusted relative risk ratio (95% CI)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Isolated angioplasty</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" colspan="3" rowspan="1">Isolated atherectomy</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Age, y</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">&#8804;64</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">65&#8211;74</td><td align="left" rowspan="1" colspan="1">0.936 (0.915&#8211;0.957)</td><td align="left" rowspan="1" colspan="1">0.911 (0.886&#8211;0.938)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">75&#8211;84</td><td align="left" rowspan="1" colspan="1">1.086 (1.070&#8211;1.103)</td><td align="left" rowspan="1" colspan="1">1.068 (1.048&#8211;1.089)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">&#8805;85</td><td align="left" rowspan="1" colspan="1">1.151 (1.124&#8211;1.179)</td><td align="left" rowspan="1" colspan="1">1.090 (1.058&#8211;1.122)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Sex</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">0.965 (0.952&#8211;0.978)</td><td align="left" rowspan="1" colspan="1">0.924 (0.908&#8211;0.940)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Race</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">White</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Non&#8208;White</td><td align="left" rowspan="1" colspan="1">1.597 (1.571&#8211;1.623)</td><td align="left" rowspan="1" colspan="1">1.324 (1.296&#8211;1.353)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Comorbidities</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">ESKD</td><td align="left" rowspan="1" colspan="1">0.991 (0.972&#8211;1.011)</td><td align="left" rowspan="1" colspan="1">0.901 (0.880&#8211;0.923)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Diabetes</td><td align="left" rowspan="1" colspan="1">0.995 (0.981&#8211;1.009)</td><td align="left" rowspan="1" colspan="1">1.161 (1.140&#8211;1.182)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Hypertension</td><td align="left" rowspan="1" colspan="1">0.708 (0.699&#8211;0.718)</td><td align="left" rowspan="1" colspan="1">0.836 (0.822&#8211;0.851)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Ever smoking</td><td align="left" rowspan="1" colspan="1">0.695 (0.685&#8211;0.704)</td><td align="left" rowspan="1" colspan="1">0.910 (0.894&#8211;0.926)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Population density of residence</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Urban</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Rural</td><td align="left" rowspan="1" colspan="1">0.835 (0.821&#8211;0.849)</td><td align="left" rowspan="1" colspan="1">0.991 (0.970&#8211;1.013)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Census region of residence</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Midwest</td><td align="left" rowspan="1" colspan="1">0.655 (0.643&#8211;0.666)</td><td align="left" rowspan="1" colspan="1">0.909 (0.888&#8211;0.930)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Northeast</td><td align="left" rowspan="1" colspan="1">0.597 (0.584&#8211;0.611)</td><td align="left" rowspan="1" colspan="1">0.702 (0.683&#8211;0.722)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">South</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">West</td><td align="left" rowspan="1" colspan="1">1.009 (0.991&#8211;1.027)</td><td align="left" rowspan="1" colspan="1">0.854 (0.835&#8211;0.873)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Other</td><td align="left" rowspan="1" colspan="1">0.759 (0.639&#8211;0.900)</td><td align="left" rowspan="1" colspan="1">0.610 (0.457&#8211;0.813)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Site of service</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Hospital</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">ASC/OBL</td><td align="left" rowspan="1" colspan="1">4.531 (4.465&#8211;4.598)</td><td align="left" rowspan="1" colspan="1">4.274 (4.196&#8211;4.352)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Year, per year</td><td align="left" rowspan="1" colspan="1">1.052 (1.050&#8211;1.054)</td><td align="left" rowspan="1" colspan="1">0.993 (0.990&#8211;0.995)</td></tr><tr><td align="left" colspan="3" rowspan="1">Isolated stent</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Age, y</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">&#8804;64</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">65&#8211;74</td><td align="left" rowspan="1" colspan="1">0.960 (0.939&#8211;0.980)</td><td align="left" rowspan="1" colspan="1">0.953 (0.931&#8211;0.976)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">75&#8211;84</td><td align="left" rowspan="1" colspan="1">0.830 (0.818&#8211;0.842)</td><td align="left" rowspan="1" colspan="1">0.866 (0.852&#8211;0.881)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">&#8805;85</td><td align="left" rowspan="1" colspan="1">0.642 (0.626&#8211;0.658)</td><td align="left" rowspan="1" colspan="1">0.703 (0.684&#8211;0.723)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Sex</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">0.933 (0.921&#8211;0.946)</td><td align="left" rowspan="1" colspan="1">0.966 (0.952&#8211;0.980)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Race</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">White</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Non&#8208;White</td><td align="left" rowspan="1" colspan="1">0.631 (0.619&#8211;0.642)</td><td align="left" rowspan="1" colspan="1">0.663 (0.649&#8211;0.677)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Comorbidities</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">ESKD</td><td align="left" rowspan="1" colspan="1">0.710 (0.696&#8211;0.725)</td><td align="left" rowspan="1" colspan="1">0.881 (0.861&#8211;0.902)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Diabetes</td><td align="left" rowspan="1" colspan="1">0.971 (0.958&#8211;0.985)</td><td align="left" rowspan="1" colspan="1">0.873 (0.859&#8211;0.887)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Hypertension</td><td align="left" rowspan="1" colspan="1">1.410 (1.390&#8211;1.431)</td><td align="left" rowspan="1" colspan="1">1.388 (1.366&#8211;1.411)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Ever smoking</td><td align="left" rowspan="1" colspan="1">1.547 (1.526&#8211;1.567)</td><td align="left" rowspan="1" colspan="1">1.287 (1.267&#8211;1.306)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Population density of residence</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Urban</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Rural</td><td align="left" rowspan="1" colspan="1">1.148 (1.130&#8211;1.166)</td><td align="left" rowspan="1" colspan="1">1.061 (1.042&#8211;1.080)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Census region of residence</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Midwest</td><td align="left" rowspan="1" colspan="1">1.001 (0.984&#8211;1.017)</td><td align="left" rowspan="1" colspan="1">0.905 (0.889&#8211;0.922)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Northeast</td><td align="left" rowspan="1" colspan="1">1.067 (1.046&#8211;1.089)</td><td align="left" rowspan="1" colspan="1">1.060 (1.036&#8211;1.083)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">South</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">West</td><td align="left" rowspan="1" colspan="1">0.757 (0.743&#8211;0.772)</td><td align="left" rowspan="1" colspan="1">0.829 (0.812&#8211;0.847)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Other</td><td align="left" rowspan="1" colspan="1">0.436 (0.357&#8211;0.534)</td><td align="left" rowspan="1" colspan="1">0.540 (0.423&#8211;0.689)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Site of service</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Hospital</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">ASC/OBL</td><td align="left" rowspan="1" colspan="1">0.588 (0.578&#8211;0.597)</td><td align="left" rowspan="1" colspan="1">0.736 (0.723&#8211;0.750)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Year, per year</td><td align="left" rowspan="1" colspan="1">0.931 (0.930&#8211;0.933)</td><td align="left" rowspan="1" colspan="1">0.956 (0.953&#8211;0.958)</td></tr><tr><td align="left" colspan="3" rowspan="1">Stent with atherectomy</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Age, y</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">&#8804;64</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">65&#8211;74</td><td align="left" rowspan="1" colspan="1">0.837 (0.811&#8211;0.864)</td><td align="left" rowspan="1" colspan="1">0.844 (0.811&#8211;0.878)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">75&#8211;84</td><td align="left" rowspan="1" colspan="1">1.027 (1.005&#8211;1.048)</td><td align="left" rowspan="1" colspan="1">1.028 (1.002&#8211;1.054)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">&#8805;85</td><td align="left" rowspan="1" colspan="1">0.994 (0.962&#8211;1.027)</td><td align="left" rowspan="1" colspan="1">0.993 (0.954&#8211;1.034)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Sex</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">0.863 (0.847&#8211;0.879)</td><td align="left" rowspan="1" colspan="1">0.854 (0.835&#8211;0.875)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Race</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">White</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Non&#8208;White</td><td align="left" rowspan="1" colspan="1">1.059 (1.035&#8211;1.084)</td><td align="left" rowspan="1" colspan="1">0.900 (0.874&#8211;0.928)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Comorbidities</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">ESKD</td><td align="left" rowspan="1" colspan="1">0.847 (0.823&#8211;0.871)</td><td align="left" rowspan="1" colspan="1">0.870 (0.841&#8211;0.899)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Diabetes</td><td align="left" rowspan="1" colspan="1">0.868 (0.851&#8211;0.885)</td><td align="left" rowspan="1" colspan="1">1.018 (0.993&#8211;1.043)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Hypertension</td><td align="left" rowspan="1" colspan="1">0.715 (0.701&#8211;0.729)</td><td align="left" rowspan="1" colspan="1">0.897 (0.876&#8211;0.918)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Ever smoking</td><td align="left" rowspan="1" colspan="1">0.884 (0.867&#8211;0.901)</td><td align="left" rowspan="1" colspan="1">1.130 (1.104&#8211;1.157)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Population density of residence</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Urban</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Rural</td><td align="left" rowspan="1" colspan="1">0.843 (0.823&#8211;0.862)</td><td align="left" rowspan="1" colspan="1">0.970 (0.942&#8211;0.998)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Census region of residence</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Midwest</td><td align="left" rowspan="1" colspan="1">0.639 (0.623&#8211;0.655)</td><td align="left" rowspan="1" colspan="1">0.896 (0.868&#8211;0.925)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Northeast</td><td align="left" rowspan="1" colspan="1">0.797 (0.774&#8211;0.820)</td><td align="left" rowspan="1" colspan="1">0.989 (0.955&#8211;1.023)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">South</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">West</td><td align="left" rowspan="1" colspan="1">0.691 (0.674&#8211;0.710)</td><td align="left" rowspan="1" colspan="1">0.610 (0.590&#8211;0.631)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Other</td><td align="left" rowspan="1" colspan="1">0.485 (0.367&#8211;0.641)</td><td align="left" rowspan="1" colspan="1">0.479 (0.324&#8211;0.709)</td></tr><tr><td align="left" style="padding-left:10%" colspan="3" rowspan="1">Site of service</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Hospital</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">ASC/OBL</td><td align="left" rowspan="1" colspan="1">5.280 (5.177&#8211;5.386)</td><td align="left" rowspan="1" colspan="1">5.849 (5.704&#8211;5.998)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Year, per year</td><td align="left" rowspan="1" colspan="1">1.030 (1.027&#8211;1.033)</td><td align="left" rowspan="1" colspan="1">0.970 (0.967&#8211;0.974)</td></tr></tbody></table><table-wrap-foot id="jah39720-ntgp-0004"><fn id="jah39720-note-0006"><p>ASC/OBL indicates ambulatory surgical center or office&#8208;based laboratory; ESRD, end&#8208;stage renal disease; and PVI, peripheral vascular intervention.</p></fn></table-wrap-foot></table-wrap></sec><sec id="jah39720-sec-0017"><title>Site of Service</title><p>Overall, the majority of PVIs were performed in hospital settings (62.8%) rather than ASC/OBLs (37.3%). Over the 12&#8208;year study period, the proportion of PVIs performed in ASC/OBLs increased significantly: a minority of PVIs (12.4%) were performed in ASC/OBLs in 2011, which became the majority (55.7%) in 2022, which is equivalent to an increase of 4.0% per year (95% CI, 3.5%&#8211;4.5%; Figure&#160;<xref rid="jah39720-fig-0003" ref-type="fig">3</xref>). In 2011, cardiologists performed 57.0% of all PVIs, but by 2022, this percentage had decreased to 47.0%. On the other hand, vascular surgeons saw an increase in their involvement, with their PVI contribution rising from 22.9% in 2011 to 33.4% in 2022 (Figure&#160;<xref rid="jah39720-fig-0004" ref-type="fig">4</xref>).</p><fig position="float" fig-type="Figure" id="jah39720-fig-0003" orientation="portrait"><label>Figure 3</label><caption><title>Proportion of PVI performed for claudication per year according to site of service.</title><p>Blue=hospital, Green=ambulatory surgical center or office&#8208;based laboratory. PVI indicates peripheral vascular interventions.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="JAH3-13-e033463-g003.jpg"/></fig><fig position="float" fig-type="Figure" id="jah39720-fig-0004" orientation="portrait"><label>Figure 4</label><caption><title>Proportion of PVI performed for claudication per year according to physician specialty.</title><p>Blue=cardiology, pink=vascular surgery, gray=radiology, green=other. PVI indicates peripheral vascular interventions.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-7" orientation="portrait" xlink:href="JAH3-13-e033463-g004.jpg"/></fig></sec><sec id="jah39720-sec-0018"><title>
<styled-content style="fixed-case" toggle="no">Medicare&#8208;Allowed</styled-content> Charges</title><p>The total Medicare&#8208;allowed charges for PVIs performed for claudication from 2011 to 2022 was $2&#8201;195&#8201;550&#8201;390, equivalent to a mean&#177;SD of $3664.15&#177;6.44 per procedure (Figure&#160;<xref rid="jah39720-fig-0005" ref-type="fig">5A</xref>). There was an absolute increase of $11&#8201;980&#8201;035 (95% CI, $4557180&#8211;$19&#8201;402&#8201;891) USD charged for PVIs performed for claudication per year. For every 1% increase in atherectomy use, Medicare&#8208;allowed charges increased by $8&#8201;244&#8201;902 (95% CI, $4476520&#8211;$12&#8201;013&#8201;284) USD. For every 1% increase in tibial PVI use, Medicare&#8208;allowed charges increased by $11&#8201;887&#8201;745 (95% CI, $5145383&#8211;$18&#8201;630&#8201;107) USD.</p><fig position="float" fig-type="Figure" id="jah39720-fig-0005" orientation="portrait"><label>Figure 5</label><caption><title>Medicare&#8208;allowed charges per year associated with PVI performed for claudication, overall (A) and by PVI type (B).</title><p>Blue=angioplasty, green=atherectomy, gray=stent, pink=stent atherectomy. APC indicates annual percentage change; and PVI, peripheral vascular interventions.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-9" orientation="portrait" xlink:href="JAH3-13-e033463-g005.jpg"/></fig><p>On a per&#8208;procedure basis, the Medicare&#8208;allowed charges for atherectomy increased from $2660&#177;40.34 per procedure in 2011 to a peak of $8256&#177;38.09 per procedure in 2019, after which there was a decline to $6931&#177;32.83 per procedure in 2022 (Figure&#160;<xref rid="jah39720-fig-0005" ref-type="fig">5B</xref>). The Medicare&#8208;allowed charges for stent with atherectomy increased from $4807&#177;105.78 per procedure in 2011 to a peak of $12&#8201;377&#177;81.75 per procedure in 2019, after which there was a decline to $10&#8201;190&#177;71.25 per procedure in 2022. The Medicare allowed&#8208;charges for isolated angioplasty ($1045&#177;3.42 USD) and isolated stent placement ($1390&#177;5.03 USD) remained relatively stable over time.</p></sec></sec><sec sec-type="discussion" id="jah39720-sec-0019"><title>DISCUSSION</title><p>In our study of 599&#8201;197 PVI procedures performed in Medicare beneficiaries with claudication, we found that tibial PVI and atherectomy have become increasingly prevalent in the treatment of claudication and have shifted from the hospital setting to ASC/OBL settings. Overall, the Medicare&#8208;allowed charges associated with PVIs are substantial and increasing over time. To the best of our knowledge, our study is the most up&#8208;to&#8208;date analysis describing the use of PVI for claudication using longitudinal, nationally representative data.</p><p>The appropriateness of invasive interventions performed for claudication depends on the anatomic level of disease. Based on the recent Society for Vascular Surgery Appropriateness Use Criteria for the management of claudication,<xref rid="jah39720-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> endovascular revascularization as initial or postsupervised exercise therapy may be appropriate for some patients with severe lifestyle limiting symptoms in the setting of aortoiliac disease. Similarly, femoropopliteal PVI may be an appropriate intervention for femoropopliteal disease causing lifestyle limiting symptoms after a trial (and failure) of exercise therapy. However, in both the 2015 Society for Vascular Surgery professional clinical guidelines<xref rid="jah39720-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> and the more recent appropriateness use criteria,<xref rid="jah39720-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> tibial interventions for the treatment of claudication are considered to pose a greater risk than benefit and are not indicated in any setting. Despite this, we found an increasing trend in the use of tibial PVIs from 2011 through 2022, with an overall increase of 12% over the past 12&#8201;years. Notably, tibial PVIs were more common in adults with diabetes, which may reflect an increased prevalence of infrapopliteal disease caused by diabetic atherosclerosis,<xref rid="jah39720-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> and in high&#8208;reimbursement (ie, ASC/OBL) settings, which may reflect the policy change from the CMS that resulted in higher reimbursement rates for these procedures. Both findings are consistent with previously reported associations of tibial PVIs performed for claudication.<xref rid="jah39720-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="jah39720-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="jah39720-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>
</p><p>Of all PVI types we investigated, the use of isolated atherectomy increased the most over the past 12&#8201;years. This raises concerns because multiple prior meta&#8208;analyses have failed to show significant benefits associated with atherectomy compared with balloon angioplasty for the treatment of PAD.<xref rid="jah39720-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, <xref rid="jah39720-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="jah39720-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> Other studies have suggested possible harms associated with atherectomy, including shorter time to claudication recurrence, more repeat procedures, and a higher rate of conversion to chronic limb&#8208;threatening ischemia, when used in the setting of claudication.<xref rid="jah39720-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="jah39720-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>, <xref rid="jah39720-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> Despite a lack of clear evidence supporting the long&#8208;term efficacy of atherectomy over other available technologies, its use increased by 1.6% per year. This temporal change is also concerning due to the high costs associated with atherectomy. Previous studies have shown that the majority of Medicare reimbursements for index femoropopliteal PVIs were attributable to atherectomy<xref rid="jah39720-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> and that atherectomy procedures are often more costly than alternative treatments such as angioplasty or stenting.<xref rid="jah39720-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> We found that atherectomy, on average, was associated with charges that are 5 to 6 times higher than those associated with angioplasty, with or without a stent.</p><p>Disparities in the treatments offered to White and non&#8208;White patients have been documented for decades. Our study adds to this literature in finding that, among patients with claudication, non&#8208;White patients were more likely to receive a tibial PVI or an atherectomy to treat their disease. Notably, for claudication, both tibial PVI and atherectomy are considered low&#8208;value procedures that should not be used routinely,<xref rid="jah39720-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> The current study adds to our previous work where we demonstrated that Black patients have significantly higher odds of receiving an early (within 6&#8201;months) PVI for claudication compared with White patients after controlling for geographic factors and county income.<xref rid="jah39720-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> Black adults undergo more PVIs than White adults at a population level and experience more adverse outcomes, including major amputation or death.<xref rid="jah39720-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> Taken together, these findings raise concerns for health equity and highlight the need for further investigation into the underlying factors contributing to these disparities. It is important to address these disparities in the use of elective PVI to ensure all patients receive appropriate and equitable care. Potential efforts to mitigate these differences include improving access to comprehensive health care services for non&#8208;White patients, providing cultural competence training for health care workers, and considering alternative treatments to low&#8208;value PVI.<xref rid="jah39720-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>, <xref rid="jah39720-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>
</p><p>There was a clear shift in the site of service at which PVIs were performed over the course of our 12&#8208;year study period. In 2011, the majority of PVIs for claudication were performed in hospital settings, and by 2022, the majority were performed in ASC/OBL settings. This shift is unsurprising, as it followed a policy change that occurred in 2008. In an effort to reduce the health care costs of outpatient services, the CMS increased reimbursement for procedures performed in nonhospital settings.<xref rid="jah39720-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref> The policy change intentionally incentivized the shift of PAD care from hospitals to outpatient settings, such as ASCs and OBLs. Early evidence of this shift was previously reported using Medicare fee&#8208;for&#8208;service data from 2006 through 2011 and showed that the rate of PVIs declined in inpatient settings and expanded in outpatient hospitals and office&#8208;based clinics.<xref rid="jah39720-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> Even a decade ago, PVI for PAD was most commonly performed in outpatient hospital settings. Our data show efficacy of the CMS policy change on this prior information and shows efficacy of the CMS policy change in effectively moving PVI for claudication out of hospital settings. Our study also shows significant increases in the prevalence of tibial PVI and atherectomy use in the treatment of claudication in high&#8208;reimbursement (ie, ASC/OBL) settings. It is possible that the CMS&#8217; goal to move PVI out of the hospital setting inadvertently resulted in overuse of certain interventions.</p><p>In this study, we also observed notable shifts in the transition in physician specialties in performing PVIs, with a discernible increase in involvement from vascular surgeons compared with cardiologists and interventional radiologists. This shift underscores the evolving landscape of vascular care and the changing roles of different medical specialties in addressing PAD. One notable paradox highlighted in our findings was the discrepancy between the increasing trends in certain procedures, such as infrapopliteal revascularization, and the limited evidence supporting their long&#8208;term clinical efficacy. Despite the rising use of infrapopliteal interventions in the treatment of claudication, there remains a paucity of long&#8208;term clinical data demonstrating their effectiveness.<xref rid="jah39720-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>, <xref rid="jah39720-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> This paradox emphasizes a potential disconnect between clinical practice guidelines and appropriate use criteria with daily clinical practice.</p><p>Importantly, our study demonstrated an overall increasing trend of PVI used to treat claudication and increasing costs associated with this trend. We found an increase in Medicare&#8208;allowed charges for claudication totaling nearly $12&#8201;million USD per year. The Medicare&#8208;allowed charges associated with atherectomy for claudication more than doubled over the past 12&#8201;years. The economic burden of PVI for claudication seems unsustainable, and the high costs associated with PVI can contribute to financial burdens for patients and their families as well as health care system inefficiencies.<xref rid="jah39720-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> To address this issue, physicians and policymakers can promote evidence&#8208;based practice and clinical guidelines for the management of claudication.<xref rid="jah39720-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> The Society for Vascular Surgery Appropriate Use Criteria is one means to accomplish this, although the influence on practice patterns in the treatment of claudication remain to be determined. Additionally, improving patient education about the risks and benefits of treatment options, and incentivizing health care providers to prioritize conservative treatment options and value&#8208;based care, could help reduce the use of PVI in the management of claudication. It is important to emphasize that PVI should generally be reserved for patients who have not responded to conservative and medical therapies, without making blanket assumptions about the appropriateness of all PVIs for claudication.</p><sec id="jah39720-sec-0020"><title>Limitations</title><p>This study has several limitations. The results are based on Medicare beneficiaries primarily aged 65&#8201;years and older, which might not be representative of the overall US population with claudication. Administrative claims data are designed primarily for billing purposes and may not capture complete patient information or health conditions, which may result in residual confounding. Specifically, there is no way to identify the degree of patient symptoms or extent of anatomic disease using claims data. There is also a possibility that patients we identified as having claudication had more advanced PAD and were misclassified. However, we have recently demonstrated that the accuracy of using claims data to identify patients with claudication in Medicare data is high (81.3%).<xref rid="jah39720-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> Drug&#8208;coated technology (balloons and stents) and intravascular lithotripsy are billed using the same Current Procedural Terminology codes as standard therapies, so we were not able to distinguish between them. We were unable to evaluate temporal trends in the medical management of claudication, as aspirin and supervised exercise therapy are frequently recommended by physicians without a documented prescription. We also did not evaluate patient outcomes in this analysis; the aim of this study was focused on temporal practice patterns in the treatment of claudication. We have reported patient&#8208;based outcomes after PVI for claudication in prior work.<xref rid="jah39720-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="jah39720-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> Finally, we observed a fluctuating trend in the total number of PVIs performed each year from 2011 to 2022. It is important to consider the potential impact of changes in Current Procedural Terminology codes on these trends and whether the decrease in procedural volume observed in the later years could be attributed to the effects of COVID&#8208;19. It is also important to note that we do not report the number of patients with claudication as a denominator in our results because we performed a procedure&#8208;level (rather than patient&#8208;level) analysis. It is possible that some of the trends we report are related to an aging population with an increased prevalence of risk factors rather than practice&#8208;specific changes alone.</p></sec></sec><sec sec-type="conclusions" id="jah39720-sec-0021"><title>CONCLUSIONS</title><p>The use of tibial PVI and atherectomy for the treatment of claudication has increased dramatically in the past decade, despite poor evidence supporting their efficacy, especially long term. This trend is most notable in ASC/OBL settings and among non&#8208;White patients and has been associated with a significant increase in health care expenditures over time. Although some of these changes may be related to an aging population, there is a critical need to improve the delivery of equitable, evidence&#8208;based, and value&#8208;based care for the treatment of claudication.</p></sec><sec id="jah39720-sec-0022"><title>Sources of Funding</title><p>None.</p></sec><sec id="jah39720-sec-0023"><title>Disclosures</title><p>Caitlin W Hicks reports relationships with Cook Medical LLC, W.L. Gore, and Silk Road Medical (speakers bureau) that are unrelated to this work. Dr Hicks is supported by a grant from the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (K23DK124515). The remaining authors have no disclosures to report.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="jah39720-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>Tables S1&#8211;S2</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JAH3-13-e033463-s001.pdf" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ref-list content-type="cited-references" id="jah39720-bibl-0001"><title>References</title><ref id="jah39720-bib-0001"><label>1</label><mixed-citation publication-type="miscellaneous" id="jah39720-cit-0001"><collab collab-type="authors">Centers for Disease Control</collab>
. <article-title>About Peripheral Artery Disease (PAD)</article-title>. Accessed October 24, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/heart-disease/about/peripheral-arterial-disease.html#:~:text=Peripheral%20arterial%20disease%20(PAD)%20in,This%20is%20called%20atherosclerosis" ext-link-type="uri">https://www.cdc.gov/heart&#8208;disease/about/peripheral&#8208;arterial&#8208;disease.html#:~:text=Peripheral%20arterial%20disease%20(PAD)%20in,This%20is%20called%20atherosclerosis</ext-link>.</mixed-citation></ref><ref id="jah39720-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="jah39720-cit-0002"><string-name name-style="western"><surname>Tummala</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Scherbel</surname><given-names>D</given-names></string-name>. <article-title>Clinical assessment of peripheral arterial disease in the office: what do the guidelines say?</article-title><source>Semin Interv Radiol</source>. <year>2019</year>;<volume>35</volume>:<fpage>365</fpage>&#8211;<lpage>377</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-0038-1676453</pub-id><pub-id pub-id-type="pmcid">PMC6363542</pub-id><pub-id pub-id-type="pmid">30728652</pub-id></mixed-citation></ref><ref id="jah39720-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="jah39720-cit-0003"><string-name name-style="western"><surname>Woo</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Siracuse</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Klingbeil</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kraiss</surname><given-names>LW</given-names></string-name>, <string-name name-style="western"><surname>Osborne</surname><given-names>NH</given-names></string-name>, <string-name name-style="western"><surname>Singh</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>T&#8208;W</given-names></string-name>, <string-name name-style="western"><surname>Arya</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Banerjee</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Bonaca</surname><given-names>MP</given-names></string-name>, et&#160;al. <article-title>Society for vascular surgery appropriate use criteria for management of intermittent claudication</article-title>. <source>J Vasc Surg</source>. <year>2022</year>;<volume>76</volume>:<fpage>3</fpage>&#8211;<lpage>22.e1</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2022.04.012</pub-id><pub-id pub-id-type="pmid">35470016</pub-id></mixed-citation></ref><ref id="jah39720-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jah39720-cit-0004"><string-name name-style="western"><surname>Guez</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Hansberry</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Gonsalves</surname><given-names>CF</given-names></string-name>, <string-name name-style="western"><surname>Eschelman</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Parker</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Rao</surname><given-names>VM</given-names></string-name>, <string-name name-style="western"><surname>Levin</surname><given-names>DC</given-names></string-name>. <article-title>Recent trends in endovascular and surgical treatment of peripheral arterial disease in the Medicare population</article-title>. <source>Am J Roentgenol</source>. <year>2020</year>;<volume>214</volume>:<fpage>962</fpage>&#8211;<lpage>966</lpage>. doi: <pub-id pub-id-type="doi">10.2214/AJR.19.21967</pub-id><pub-id pub-id-type="pmid">32097027</pub-id></mixed-citation></ref><ref id="jah39720-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="jah39720-cit-0005"><string-name name-style="western"><surname>Bose</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Dun</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Sorber</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Stonko</surname><given-names>DP</given-names></string-name>, <string-name name-style="western"><surname>Solomon</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Black</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Lum</surname><given-names>Y&#8208;W</given-names></string-name>, <string-name name-style="western"><surname>Conte</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Makary</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Hicks</surname><given-names>CW</given-names></string-name>. <article-title>Practice patterns surrounding the use of tibial interventions for claudication in the Medicare population</article-title>. <source>J Vasc Surg</source>. <year>2023</year>;<volume>77</volume>:<fpage>454</fpage>&#8211;<lpage>462.e1</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2022.08.033</pub-id><pub-id pub-id-type="pmid">36058433</pub-id><pub-id pub-id-type="pmcid">PMC9868091</pub-id></mixed-citation></ref><ref id="jah39720-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jah39720-cit-0006"><string-name name-style="western"><surname>Hicks</surname><given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>Holscher</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Black</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Abularrage</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Makary</surname><given-names>MA</given-names></string-name>. <article-title>Overuse of early peripheral vascular interventions for claudication</article-title>. <source>J Vasc Surg</source>. <year>2020</year>;<volume>71</volume>:<fpage>121</fpage>&#8211;<lpage>130.e1</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2019.05.005</pub-id><pub-id pub-id-type="pmid">31208940</pub-id></mixed-citation></ref><ref id="jah39720-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jah39720-cit-0007"><string-name name-style="western"><surname>Hicks</surname><given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>Holscher</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Dun</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Abularrage</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Black</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Hodgson</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Makary</surname><given-names>MA</given-names></string-name>. <article-title>Use of atherectomy during index peripheral vascular interventions</article-title>. <source>J Am Coll Cardiol Intv</source>. <year>2021</year>;<volume>14</volume>:<fpage>678</fpage>&#8211;<lpage>688</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jcin.2021.01.004</pub-id><pub-id pub-id-type="pmcid">PMC9069395</pub-id><pub-id pub-id-type="pmid">33736774</pub-id></mixed-citation></ref><ref id="jah39720-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jah39720-cit-0008"><string-name name-style="western"><surname>Kawaji</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Dun</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Walsh</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Sorber</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Stonko</surname><given-names>DP</given-names></string-name>, <string-name name-style="western"><surname>Abularrage</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Black</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Perler</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Makary</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Hicks</surname><given-names>CW</given-names></string-name>. <article-title>Index atherectomy peripheral vascular interventions performed for claudication are associated with more reinterventions than nonatherectomy interventions</article-title>. <source>J Vasc Surg</source>. <year>2022</year>;<volume>76</volume>:<fpage>489</fpage>&#8211;<lpage>498.e4</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2022.02.034</pub-id><pub-id pub-id-type="pmid">35276258</pub-id><pub-id pub-id-type="pmcid">PMC9329163</pub-id></mixed-citation></ref><ref id="jah39720-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jah39720-cit-0009"><string-name name-style="western"><surname>Sorber</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Dun</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Kawaji</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Abularrage</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Black</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Makary</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Hicks</surname><given-names>CW</given-names></string-name>. <article-title>Early peripheral vascular interventions for claudication are associated with higher rates of late interventions and progression to chronic limb threatening ischemia</article-title>. <source>J Vasc Surg</source>. <year>2023</year>;<volume>77</volume>:<fpage>836</fpage>&#8211;<lpage>847.e3</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2022.10.025</pub-id><pub-id pub-id-type="pmid">37276171</pub-id><pub-id pub-id-type="pmcid">PMC10242207</pub-id></mixed-citation></ref><ref id="jah39720-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jah39720-cit-0010"><string-name name-style="western"><surname>Haqqani</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Alonso</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kobzeva&#8208;Herzog</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Farber</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>King</surname><given-names>EG</given-names></string-name>, <string-name name-style="western"><surname>Meltzer</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Eslami</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Garg</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Rybin</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Siracuse</surname><given-names>JJ</given-names></string-name>. <article-title>Variations in practice patterns for peripheral vascular interventions across clinical settings</article-title>. <source>Ann Vasc Surg</source>. <year>2023</year>;<volume>92</volume>:<fpage>24</fpage>&#8211;<lpage>32</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.avsg.2023.01.010</pub-id><pub-id pub-id-type="pmid">36642163</pub-id></mixed-citation></ref><ref id="jah39720-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="jah39720-cit-0011"><string-name name-style="western"><surname>Hicks</surname><given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>Ding</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Kwak</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Ballew</surname><given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Kalbaugh</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Folsom</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Heiss</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Coresh</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Black</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Selvin</surname><given-names>E</given-names></string-name>, et&#160;al. <article-title>Risk of peripheral artery disease according to race and sex: the atherosclerosis risk in communities (ARIC) study</article-title>. <source>Atherosclerosis</source>. <year>2021</year>;<volume>324</volume>:<fpage>52</fpage>&#8211;<lpage>57</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2021.03.031</pub-id><pub-id pub-id-type="pmid">33823370</pub-id><pub-id pub-id-type="pmcid">PMC8096721</pub-id></mixed-citation></ref><ref id="jah39720-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jah39720-cit-0012"><string-name name-style="western"><surname>Jain</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Velazquez&#8208;Ramirez</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Goodney</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Edwards</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Corriere</surname><given-names>M</given-names></string-name>. <article-title>Gender&#8208;based analysis of perioperative outcomes associated with lower extremity bypass</article-title>. <source>Am Surg</source>. <year>2011</year>;<volume>77</volume>:<fpage>844</fpage>&#8211;<lpage>849</lpage>. doi: <pub-id pub-id-type="doi">10.1177/000313481107700717</pub-id><pub-id pub-id-type="pmid">21944345</pub-id><pub-id pub-id-type="pmcid">PMC5292262</pub-id></mixed-citation></ref><ref id="jah39720-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="jah39720-cit-0013"><string-name name-style="western"><surname>Egorova</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Vouyouka</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Quin</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Guillerme</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Moskowitz</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Marin</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Faries</surname><given-names>PL</given-names></string-name>. <article-title>Analysis of gender&#8208;related differences in lower extremity peripheral arterial disease</article-title>. <source>J Vasc Surg</source>. <year>2010</year>;<volume>51</volume>:<fpage>372</fpage>&#8211;<lpage>378.e1</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2009.09.006</pub-id><pub-id pub-id-type="pmid">20022204</pub-id></mixed-citation></ref><ref id="jah39720-bib-0014"><label>14</label><mixed-citation publication-type="miscellaneous" id="jah39720-cit-0014"><collab collab-type="authors">Research Data Assistance Center</collab>
. <article-title>Master Beneficiary Summary File (MBSF) base</article-title>. Accessed October 24, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://resdac.org/cms-data/files/mbsf-base" ext-link-type="uri">https://resdac.org/cms&#8208;data/files/mbsf&#8208;base</ext-link>.</mixed-citation></ref><ref id="jah39720-bib-0015"><label>15</label><mixed-citation publication-type="miscellaneous" id="jah39720-cit-0015"><collab collab-type="authors">National Bureau of Economic Research</collab>
. <article-title>Census Core&#8208;Based Statistical Area (CBSA) to Federal Information Processing Series (FIPS) county crosswalk</article-title>. Accessed October 24, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.nber.org/research/data/census-core-based-statistical-area-cbsa-federal-information-processing-series-fips-county-crosswalk" ext-link-type="uri">https://www.nber.org/research/data/census&#8208;core&#8208;based&#8208;statistical&#8208;area&#8208;cbsa&#8208;federal&#8208;information&#8208;processing&#8208;series&#8208;fips&#8208;county&#8208;crosswalk</ext-link>.</mixed-citation></ref><ref id="jah39720-bib-0016"><label>16</label><mixed-citation publication-type="miscellaneous" id="jah39720-cit-0016"><collab collab-type="authors">National Geographic</collab>
. <article-title>United States Regions</article-title>. Accessed October 24, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://education.nationalgeographic.org/resource/united-states-regions/" ext-link-type="uri">https://education.nationalgeographic.org/resource/united&#8208;states&#8208;regions/</ext-link>.</mixed-citation></ref><ref id="jah39720-bib-0017"><label>17</label><mixed-citation publication-type="miscellaneous" id="jah39720-cit-0017"><collab collab-type="authors">Research Data Assistance Center</collab>
. <article-title>Claim place of service code</article-title>. Accessed October 24, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://resdac.org/cms-data/variables/claim-place-service-code" ext-link-type="uri">https://resdac.org/cms&#8208;data/variables/claim&#8208;place&#8208;service&#8208;code</ext-link>.</mixed-citation></ref><ref id="jah39720-bib-0018"><label>18</label><mixed-citation publication-type="miscellaneous" id="jah39720-cit-0018"><collab collab-type="authors">Research Data Assistance Center</collab>
. <article-title>Line allowed charge amount</article-title>. Accessed October 24, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://resdac.org/cms-data/variables/line-allowed-charge-amount#:~:text=The%20amount%20of%20allowed%20charges,i.e.%2C%20deductible%20and%20coinsurance" ext-link-type="uri">https://resdac.org/cms&#8208;data/variables/line&#8208;allowed&#8208;charge&#8208;amount#:~:text=The%20amount%20of%20allowed%20charges,i.e.%2C%20deductible%20and%20coinsurance</ext-link>.</mixed-citation></ref><ref id="jah39720-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jah39720-cit-0019"><string-name name-style="western"><surname>Conte</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Pomposelli</surname><given-names>FB</given-names></string-name>, <string-name name-style="western"><surname>Clair</surname><given-names>DG</given-names></string-name>, <string-name name-style="western"><surname>Geraghty</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>McKinsey</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Mills</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Moneta</surname><given-names>GL</given-names></string-name>, <string-name name-style="western"><surname>Murad</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Powell</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Reed</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>Schanzer</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sidawy</surname><given-names>AN</given-names></string-name>. <article-title>Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication</article-title>. <source>J Vasc Surg</source>. <year>2015</year>;<volume>61</volume>:<fpage>2S</fpage>&#8208;<lpage>41S</lpage>.e1.<pub-id pub-id-type="pmid">25638515</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jvs.2014.12.009</pub-id></mixed-citation></ref><ref id="jah39720-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jah39720-cit-0020"><string-name name-style="western"><surname>Mustapha</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Diaz&#8208;Sandoval</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Saab</surname><given-names>F</given-names></string-name>. <article-title>Infrapopliteal calcification patterns in critical limb ischemia: diagnostic, pathologic and therapeutic implications in the search for the endovascular holy grail</article-title>. <source>J Cardiovasc Surg</source>. <year>2017</year>;<volume>58</volume>(<issue>3</issue>):<fpage>383</fpage>&#8211;<lpage>401</lpage>.<pub-id pub-id-type="pmid">28240525</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.23736/S0021-9509.17.09878-0</pub-id></mixed-citation></ref><ref id="jah39720-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jah39720-cit-0021"><string-name name-style="western"><surname>Turley</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Mi</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Qualls</surname><given-names>LG</given-names></string-name>, <string-name name-style="western"><surname>Vemulapalli</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Peterson</surname><given-names>ED</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Curtis</surname><given-names>LH</given-names></string-name>, <string-name name-style="western"><surname>Jones</surname><given-names>WS</given-names></string-name>. <article-title>The effect of clinical care location on clinical outcomes after peripheral vascular intervention in Medicare beneficiaries</article-title>. <source>JACC Cardiovasc Interv</source>. <year>2017</year>;<volume>10</volume>:<fpage>1161</fpage>&#8211;<lpage>1171</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jcin.2017.03.033</pub-id><pub-id pub-id-type="pmid">28595885</pub-id></mixed-citation></ref><ref id="jah39720-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="jah39720-cit-0022"><string-name name-style="western"><surname>Diamantopoulos</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Katsanos</surname><given-names>K</given-names></string-name>. <article-title>Atherectomy of the femoropopliteal artery: a systematic review and meta&#8208;analysis of randomized controlled trials</article-title>. <source>J Cardiovasc Surg</source>. <year>2014</year>;<volume>55</volume>:<fpage>655</fpage>&#8211;<lpage>665</lpage>.<pub-id pub-id-type="pmid">25008063</pub-id></mixed-citation></ref><ref id="jah39720-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="jah39720-cit-0023"><string-name name-style="western"><surname>Wu</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Pu</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Qin</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Ye</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>X</given-names></string-name>. <article-title>Atherectomy combined with balloon angioplasty versus balloon angioplasty alone for de novo femoropopliteal arterial diseases: a systematic review and meta&#8208;analysis of randomised controlled trials</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>2021</year>;<volume>62</volume>:<fpage>65</fpage>&#8211;<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ejvs.2021.02.012</pub-id><pub-id pub-id-type="pmid">34112574</pub-id></mixed-citation></ref><ref id="jah39720-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="jah39720-cit-0024"><string-name name-style="western"><surname>Ambler</surname><given-names>GK</given-names></string-name>, <string-name name-style="western"><surname>Radwan</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Hayes</surname><given-names>PD</given-names></string-name>, <string-name name-style="western"><surname>Twine</surname><given-names>CP</given-names></string-name>. <article-title>Atherectomy for peripheral arterial disease</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2014</year>:<elocation-id>CD006680</elocation-id>. doi: <pub-id pub-id-type="doi">10.1002/14651858.CD006680.pub2</pub-id><pub-id pub-id-type="pmid">24638972</pub-id></mixed-citation></ref><ref id="jah39720-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="jah39720-cit-0025"><string-name name-style="western"><surname>Bath</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lawrence</surname><given-names>PF</given-names></string-name>, <string-name name-style="western"><surname>Neal</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Beck</surname><given-names>AW</given-names></string-name>, <string-name name-style="western"><surname>Conte</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Schermerhorn</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Woo</surname><given-names>K</given-names></string-name>. <article-title>Endovascular interventions for claudication do not meet minimum standards for the Society for Vascular Surgery efficacy guidelines</article-title>. <source>J Vasc Surg</source>. <year>2021</year>;<volume>73</volume>:<fpage>1693</fpage>&#8211;<lpage>1700.e3</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2020.10.067</pub-id><pub-id pub-id-type="pmid">33253869</pub-id><pub-id pub-id-type="pmcid">PMC8189641</pub-id></mixed-citation></ref><ref id="jah39720-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="jah39720-cit-0026"><string-name name-style="western"><surname>Mukherjee</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Contos</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Emery</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Collins</surname><given-names>DT</given-names></string-name>, <string-name name-style="western"><surname>Black</surname><given-names>JH</given-names></string-name>. <article-title>High reintervention and amputation rates after outpatient atherectomy for claudication</article-title>. <source>Vasc Endovasc Surg</source>. <year>2018</year>;<volume>52</volume>:<fpage>427</fpage>&#8211;<lpage>433</lpage>. doi: <pub-id pub-id-type="doi">10.1177/1538574418772459</pub-id><pub-id pub-id-type="pmid">29716476</pub-id></mixed-citation></ref><ref id="jah39720-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="jah39720-cit-0027"><string-name name-style="western"><surname>Guzman</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Simpfendorfer</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Fix</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Franco</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Whitlow</surname><given-names>PL</given-names></string-name>. <article-title>Comparison of costs of new atherectomy devices and balloon angioplasty for coronary artery disease</article-title>. <source>Am J Cardiol</source>. <year>1994</year>;<volume>74</volume>:<fpage>22</fpage>&#8211;<lpage>25</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0002-9149(94)90485-5</pub-id><pub-id pub-id-type="pmid">8017300</pub-id></mixed-citation></ref><ref id="jah39720-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="jah39720-cit-0028"><string-name name-style="western"><surname>Bailey</surname><given-names>Steven R.</given-names></string-name>, <string-name name-style="western"><surname>Beckman</surname><given-names>Joshua A.</given-names></string-name>, <string-name name-style="western"><surname>Dao</surname><given-names>Timothy D.</given-names></string-name>, <string-name name-style="western"><given-names>Misra</given-names><surname>Sanjay</surname></string-name>, <string-name name-style="western"><surname>Sobieszczyk</surname><given-names>Piotr S.</given-names></string-name>, <string-name name-style="western"><surname>White</surname><given-names>Christopher J.</given-names></string-name>, <string-name name-style="western"><given-names>Wann L.</given-names><surname>Samuel</surname></string-name>, <string-name name-style="western"><surname>Bailey</surname><given-names>Steven R.</given-names></string-name>, <string-name name-style="western"><given-names>Dao</given-names><surname>Timothy</surname></string-name>, <string-name name-style="western"><surname>Aronow</surname><given-names>Herbert D.</given-names></string-name>, <string-name name-style="western"><given-names>Fazel</given-names><surname>Reza</surname></string-name>, <string-name name-style="western"><surname>Gornik</surname><given-names>Heather L.</given-names></string-name>, <string-name name-style="western"><surname>Gray</surname><given-names>Bruce H.</given-names></string-name>, <string-name name-style="western"><surname>Halperin</surname><given-names>Jonathan L.</given-names></string-name>, <string-name name-style="western"><surname>Hirsch</surname><given-names>Alan T.</given-names></string-name>, et&#160;al. ACC/AHA/SCAI/SIR/SVM <year>2018</year><article-title>Appropriate use criteria for peripheral artery intervention</article-title>. <source>J Am Coll Cardiol</source><volume>2019</volume>;<issue>73</issue>:<fpage>214</fpage>&#8211;<lpage>237</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacc.2018.10.002</pub-id><pub-id pub-id-type="pmcid">PMC11520195</pub-id><pub-id pub-id-type="pmid">30573393</pub-id></mixed-citation></ref><ref id="jah39720-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="jah39720-cit-0029"><string-name name-style="western"><surname>Hicks</surname><given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Bruhn</surname><given-names>WE</given-names></string-name>, <string-name name-style="western"><surname>Abularrage</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Lum</surname><given-names>YW</given-names></string-name>, <string-name name-style="western"><surname>Perler</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Black</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Makary</surname><given-names>MA</given-names></string-name>. <article-title>Race and socioeconomic differences associated with endovascular peripheral vascular interventions for newly diagnosed claudication</article-title>. <source>J Vasc Surg</source>. <year>2020</year>;<volume>72</volume>:<fpage>611</fpage>&#8211;<lpage>621.e5</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2019.10.075</pub-id><pub-id pub-id-type="pmid">31902593</pub-id><pub-id pub-id-type="pmcid">PMC7731457</pub-id></mixed-citation></ref><ref id="jah39720-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="jah39720-cit-0030"><string-name name-style="western"><surname>Krawisz</surname><given-names>AK</given-names></string-name>, <string-name name-style="western"><surname>Natesan</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wadhera</surname><given-names>RK</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Song</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yeh</surname><given-names>RW</given-names></string-name>, <string-name name-style="western"><surname>Jaff</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Giri</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Julien</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Secemsky</surname><given-names>EA</given-names></string-name>. <article-title>Differences in comorbidities explain Black&#8211;White disparities in outcomes after femoropopliteal endovascular intervention</article-title>. <source>Circulation</source>. <year>2022</year>;<volume>146</volume>:<fpage>191</fpage>&#8211;<lpage>200</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.122.058998</pub-id><pub-id pub-id-type="pmid">35695005</pub-id><pub-id pub-id-type="pmcid">PMC9308741</pub-id></mixed-citation></ref><ref id="jah39720-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="jah39720-cit-0031"><string-name name-style="western"><surname>Nair</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Adetayo</surname><given-names>OA</given-names></string-name>. <article-title>Cultural competence and ethnic diversity in healthcare</article-title>. <source>Plast Reconstr Surg Glob Open</source>. <year>2019</year>;<fpage>7</fpage>. doi: <pub-id pub-id-type="doi">10.1097/GOX.0000000000002219</pub-id><pub-id pub-id-type="pmcid">PMC6571328</pub-id><pub-id pub-id-type="pmid">31333951</pub-id></mixed-citation></ref><ref id="jah39720-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="jah39720-cit-0032"><string-name name-style="western"><surname>Stubbe</surname><given-names>DE</given-names></string-name>. <article-title>Practicing cultural competence and cultural humility in the care of diverse patients</article-title>. <source>Focus</source>. <year>2020</year>;<volume>18</volume>:<fpage>49</fpage>&#8211;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1176/appi.focus.20190041</pub-id><pub-id pub-id-type="pmid">32047398</pub-id><pub-id pub-id-type="pmcid">PMC7011228</pub-id></mixed-citation></ref><ref id="jah39720-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="jah39720-cit-0033"><collab collab-type="authors">Centers for Medicare &amp; Medicaid Services (CMS), HHS. Medicare program; prospective payment system for long&#8208;term care hospitals RY</collab>
. <article-title>2008: Annual payment rate updates, and policy changes; and hospital direct and indirect graduate medical education policy changes. Final rule</article-title>. <source>Fed Regist</source>. <year>2007</year>;<issue>72</issue>:<fpage>26869</fpage>&#8211;<lpage>27029</lpage>.<pub-id pub-id-type="pmid">17520779</pub-id></mixed-citation></ref><ref id="jah39720-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="jah39720-cit-0034"><string-name name-style="western"><surname>Jones</surname><given-names>WS</given-names></string-name>, <string-name name-style="western"><surname>Mi</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Qualls</surname><given-names>LG</given-names></string-name>, <string-name name-style="western"><surname>Vemulapalli</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Peterson</surname><given-names>ED</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Curtis</surname><given-names>LH</given-names></string-name>. <article-title>Trends in settings for peripheral vascular intervention and the effect of changes in the outpatient prospective payment system</article-title>. <source>J Am Coll Cardiol</source>. <year>2015</year>;<volume>65</volume>:<fpage>920</fpage>&#8211;<lpage>927</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jacc.2014.12.048</pub-id><pub-id pub-id-type="pmid">25744009</pub-id></mixed-citation></ref><ref id="jah39720-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="jah39720-cit-0035"><string-name name-style="western"><surname>Bose</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Dun</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Keegan</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>McDermott</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Stonko</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Black</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Columbo</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Conte</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Deery</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Goodney</surname><given-names>P</given-names></string-name>, et&#160;al. <article-title>Infrapopliteal peripheral vascular interventions for claudication are associated with poor long&#8208;term outcomes regardless of anatomical and disease severity</article-title>. <source>J Vasc Surg</source>. <year>2023</year>;<volume>77</volume>:<fpage>E83</fpage>&#8211;<lpage>E84</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2023.03.094</pub-id></mixed-citation></ref><ref id="jah39720-bib-0036"><label>36</label><mixed-citation publication-type="miscellaneous" id="jah39720-cit-0036"><collab collab-type="authors">Anon</collab>
. <article-title>Society for vascular surgery|Choosing wisely</article-title>. <year>2015</year>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://vascularspecialistonline.com/choosing-wisely-a-good-start-to-explaining-vascular-best-practices/" ext-link-type="uri">https://vascularspecialistonline.com/choosing&#8208;wisely&#8208;a&#8208;good&#8208;start&#8208;to&#8208;explaining&#8208;vascular&#8208;best&#8208;practices/</ext-link>.</mixed-citation></ref></ref-list></back></article></pmc-articleset>